About Amorcyte Leadership Investors Technology Clinical Trials Corporate Development News & Events Scientific Advisory Board Andrew L. Pecora, MD Founder and Chief Scientific Officer Eugene Braunwald M.D., M.D. (hon), Sc.D. (hon), F.R.C.P. Distinguished Hersey Professor of Medicine at Harvard Medical School, and Chairman of the TIMI Study Group at the Brigham and Women's Hospital Bernard J. Gersh, MB ChB, D.Phil Professor of Medicine at Mayo Clinic of Medicine and Consultant in Cardiovascular Diseases Dean J. Kereiakes, MD, FACC Medical Director, The Christ Hospital Heart and Vascular Center , The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital Douglas L. Mann, MD Lewis Chair and Chief, Cardiovascular Division, Professor of Medicine, Cell Biology and Physiology, Washington University School of Medicine, Cardiologist-in-Chief, Barnes Jewish Hospital Carl J. Pepine, MD Professor of Medicine and Chief, Division of Cardiovascular Medicine at the University of Florida College of Medicine Emerson C. Perin, MD, PhD, FACC Director, New Interventional Cardiovascular Technology, Texas Heart Institute Bertram Pitt, M.D. Professor of Internal Medicine, University of Michigan School of Medicine Arshed A. Quyyumi, MD, FRCP, FACC Professor of Medicine, Cardiology, Emory University School of Medicine Edmund Waller, MD, PhD, FACP Professor of Medicine at Emory Health Care Division of Cardiology James T. Willerson, MD President University of Texas Health Science Center Joseph Wu, M.D., Ph.D., FACC, FAHA Associate Professor, Department of Medicine (Cardiology) and Department of Radiology, Stanford School of Medicine